Literature DB >> 8917235

Candida albicans arthritis one year after successful treatment of fungemia in a healthy infant.

H Swanson1, P A Hughes, S A Messer, M L Lepow, M A Pfaller.   

Abstract

Fungal arthritis in pediatric patients is rare and is most often associated with hematogenous spread to the affected joint. It is generally seen concomitant with, or shortly after, fungemia. We report a case of an immunocompetent patient in whom candidal arthritis developed 1 year after initial fungemia. The initial candidiasis was considered to be adequately treated with amphotericin B. The Candida isolates from the neonatal fungemia and subsequent arthritis were the some as identified by electrophoretic karyotype, restriction fragment length polymorphism analysis, and antifungal susceptibility testing. Pediatric candidal fungemia, arthritis, and their treatments are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917235     DOI: 10.1016/s0022-3476(96)70151-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Duration of antifungal treatment and development of delayed complications in patients with candidaemia.

Authors:  A M L Oude Lashof; J P Donnelly; J F G M Meis; J W M van der Meer; B J Kullberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-25       Impact factor: 3.267

3.  Fungal arthritis of the hip in patient with aplastic anaemia.

Authors:  Ronan Le Calloch; Jean-Christophe Ianotto; Gaëlle Guillerm; Jean Marie Tonnelier
Journal:  BMJ Case Rep       Date:  2013-08-13

4.  Candida Arthritis: Analysis of 112 Pediatric and Adult Cases.

Authors:  Maria N Gamaletsou; Blandine Rammaert; Marimelle A Bueno; Nikolaos V Sipsas; Brad Moriyama; Dimitrios P Kontoyiannis; Emmanuel Roilides; Valerie Zeller; Saad J Taj-Aldeen; Andy O Miller; Ruta Petraitiene; Olivier Lortholary; Thomas J Walsh
Journal:  Open Forum Infect Dis       Date:  2015-12-23       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.